Is mesalamine approved and sold in Asian countries?
Mesalamine (5-aminosalicylic acid; 5-ASA) is used worldwide for inflammatory bowel diseases like ulcerative colitis and is available in many Asian markets as prescription medicines. Availability varies by country and by formulation (for example, tablets, capsules, or rectal forms such as suppositories/enemas).
Why does availability differ across Asia?
Even within Asia, countries differ in:
- Whether mesalamine is specifically approved for ulcerative colitis/IBD
- Which versions are marketed (oral vs. rectal; different delayed-release or controlled-release products)
- Whether the market uses branded products or generics
What to search for if a brand name isn’t listed?
If you are checking a pharmacy or an online listing, mesalamine may appear under terms like:
- "mesalazine" (a common alternative spelling)
- "5-ASA"
- Product names that include "5-aminosalicylic acid"
What if you tell me the country?
If you share the specific country (for example, India, Japan, China, South Korea, Thailand, or the Philippines), I can narrow the answer to the most likely local naming and whether it’s commonly available there.